Cargando…
Serum Sclerostin in Hepatitis C Virus Infected Patients
BACKGROUND: Sclerostin inhibits osteoblast functions, differentiations, and survival rates. As an endogenous inhibitor of the Wnt/β-catenin pathway, the sclerostin should be related to decreased bone masses, although several studies indicate opposite results. In addition, it may be related to insuli...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society for Bone and Mineral Research
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970296/ https://www.ncbi.nlm.nih.gov/pubmed/24707469 http://dx.doi.org/10.11005/jbm.2014.21.1.69 |